Willow Biosciences Inc.
CANSF
$0.02
-$0.0035-14.89%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.01M | -4.54M | -5.68M | -6.43M | -7.88M |
| Total Depreciation and Amortization | 1.02M | 1.27M | 1.02M | 1.21M | 1.28M |
| Total Amortization of Deferred Charges | 4.30K | 4.30K | 6.60K | 6.60K | 6.60K |
| Total Other Non-Cash Items | 237.50K | 238.30K | 309.00K | -67.20K | -40.70K |
| Change in Net Operating Assets | 545.50K | 550.60K | 1.01M | 865.50K | 10.50K |
| Cash from Operations | -1.47M | -2.74M | -3.33M | -4.42M | -6.62M |
| Capital Expenditure | -14.70K | -14.70K | -47.00K | -54.70K | -59.90K |
| Sale of Property, Plant, and Equipment | 0.00 | 100.10K | 105.20K | 105.20K | 105.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.20K | -28.20K | -33.70K | 43.50K | 48.00K |
| Cash from Investing | -42.80K | 57.30K | 24.60K | 94.10K | 93.40K |
| Total Debt Issued | -270.00K | -270.00K | 2.14M | 1.35M | 800.00K |
| Total Debt Repaid | -927.00K | -860.00K | -787.00K | -1.00M | -1.04M |
| Issuance of Common Stock | 2.00K | 2.00K | 2.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.93M | 1.91M | 38.00K | 290.00K | 227.00K |
| Cash from Financing | 542.50K | 581.30K | 1.02M | 463.20K | -10.00K |
| Foreign Exchange rate Adjustments | 18.50K | 34.00K | -18.30K | -19.80K | -38.30K |
| Miscellaneous Cash Flow Adjustments | -103.10K | 1.40K | 222.60K | -402.90K | -3.20K |
| Net Change in Cash | -1.05M | -2.06M | -2.08M | -4.28M | -6.58M |